{
  "id": "ea8a0375fdc9f081",
  "title": "Takeda Rises After AI-Developed Psoriasis Pill Trial Success",
  "description": "Takeda Pharmaceutical Co. rose the most in seven months on Friday after the drugmaker said its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, marking a milestone in its effort to treat the incurable skin condition.",
  "content": "Takeda Pharmaceutical Co. rose the most in seven months on Friday after the drugmaker said its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, marking a milestone in its effort to treat the incurable skin condition.",
  "source": "Bloomberg Markets",
  "source_url": "https://www.bloomberg.com/news/articles/2025-12-18/takeda-s-ai-developed-psoriasis-pill-succeeds-in-clinical-trials",
  "published_at": "2025-12-18T09:02:00+00:00",
  "fetched_at": "2025-12-19T00:23:08.544189+00:00",
  "category": "macroeconomics_finance",
  "subcategory": null,
  "keywords": [
    "ai",
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "Takeda Rises After AI-Developed Psoriasis Pill Trial Success",
    "description": "Takeda Pharmaceutical Co. rose the most in seven months on Friday after the drugmaker said its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, marking a milestone in its effort to treat the incurable skin condition.",
    "url": "https://www.bloomberg.com/news/articles/2025-12-18/takeda-s-ai-developed-psoriasis-pill-succeeds-in-clinical-trials",
    "published": "2025-12-18T09:02:00+00:00",
    "source": "Bloomberg Markets"
  }
}